KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan

PLoS ONE - United States
doi 10.1371/journal.pone.0083381
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

miR-122, IL28B Genotype and the Response to Interferon in Chronic Hepatitis C Virus Infection

Nature Reviews Immunology
MedicineAllergyImmunology
2013English

Dysregulation of Innate Immunity in Hepatitis C Virus Genotype 1 IL28B-unfavorable Genotype Patients: Impaired Viral Kinetics and Therapeutic Response

Hepatology
MedicineHepatology
2012English

Vitamin D Levels and IL28B Polymorphisms Are Related to Rapid Virological Response to Standard of Care in Genotype 1 Chronic Hepatitis C

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

An Index to Predict Ribavirin-Induced Anemia in Asian Patients With Chronic Genotype 1 Hepatitis C

Hepatitis Monthly
HepatologyInfectious Diseases
2015English

Can Gender Predict Virological Response to Standard Antiviral Therapy for Chronic Hepatitis C? A Retrospective Study

Hepatoma Research
2016English

Predict of the Development of Lipid Distress Syndrome in Patients With a Sustained Response to Antiviral Therapy of Chronic Hepatitis C

Jurnal Infektologii
Infectious Diseases
2019English

Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4

PLoS ONE
Multidisciplinary
2015English

Beneficial IL28B Genotype Associated With Lower Frequency of Hepatic Steatosis in Patients With Chronic Hepatitis C

Journal of Hepatology
Hepatology
2011English

sPECAM-1 and sVCAM-1: Role in Pathogenesis and Diagnosis of Chronic Hepatitis C and Association With Response to Antiviral Therapy

Therapeutic Advances in Gastroenterology
Gastroenterology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy